Here are four key points:
1. The acquisition costs include $125 million up front and up to an additional $85 million over the next five years, which is contingent on financial performance.
2. Rotation Medical is the developer of an innovative tissue regeneration technology for shoulder rotator cuff repair. Smith & Nephew believes the system will compliment its current shoulder repair technologies portfolio.
3. Rotation Medical’s regeneration technology will be sold through Smith & Nephew’s sports medicine task force and the integrated Rotation Medical sales team.
4. The rotator cuff repair technology is approved for sale in the U.S., and Smith & Nephew filed for approval in Europe.
More articles on devices and implants:
FDA releases new guidance for 3-D printing medical devices: 5 things to know
Exactech receives $737M offer from TPG Capital to purchase the company: 3 notes
Global spinal fusion devices market to reach nearly $11B by 2025: 6 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
